Apple’s health pages love two little words: “FDA cleared.” They show up next to the ECG app, sleep apnea notifications, and the newer hypertension alerts.
Most people read them as “the government says this works,” and that’s only partly right. The phrase has a specific legal meaning, it covers some Watch features and not others, and it comes with limits that Apple prints in documents almost nobody opens. If you’ve ever wondered why your Watch can flag a possible heart rhythm problem but your step count carries no such badge, or why a feature launches in the US months before it reaches your country, the answer sits in how medical device rules work. Here’s a plain-English tour of what that label tells you, and what it doesn’t.
Cleared, Approved, or Just a Wellness Feature
The FDA doesn’t treat every health number on your wrist the same way. It sorts devices by risk, and the review path depends on where a product lands.
“Approved” is the strictest tier. It comes from Premarket Approval (PMA), the route for high-risk devices like implanted heart valves, and it usually requires extensive clinical evidence. None of the Apple Watch features discussed here went through it.
“Cleared” usually means a 510(k): the company shows its product is substantially equivalent to a device the FDA already allows on the market. When nothing comparable exists yet, the company can file a De Novo request instead, and if the FDA grants it, that product becomes the reference point for future 510(k) filings.
Then there’s everything else. Step counts, Activity rings, and heart rate readings during a workout are general wellness features. The FDA doesn’t review them as medical devices, which is fine for tracking a morning run but means nobody has checked them against a diagnostic standard.
Which Watch Features Carry the Label
A handful of Apple Watch features have actually gone through FDA review:
- ECG app: granted De Novo authorization on September 11, 2018, which created a new category: over-the-counter ECG software.
- Irregular rhythm notifications: also authorized through De Novo in 2018, alongside the ECG app.
- AFib History: cleared through 510(k) in 2022 for people already diagnosed with AFib.
- Sleep apnea notifications: cleared through 510(k) in September 2024.
- Hypertension notifications: cleared by the FDA in September 2025.
Each of these is software. The sensors already sit inside the Watch; what the FDA reviewed was the algorithm that turns raw sensor data into a health claim. Regulators call that software as a medical device, and it lives under rules your fitness apps never touch: a documented quality management system, risk analysis, clinical validation studies, and a paper trail for every update. It’s the same discipline that governs medical device software development for hospital and clinic tools, and it’s a big reason these features take years to arrive rather than one software cycle.
The Fine Print Called “Intended Use”
Every cleared feature ships with an “intended use” statement, and it matters more than the badge itself. The FDA reviewed the feature for a specific group of people doing a specific thing. Outside that group, the clearance doesn’t apply.
Apple’s own instructions for irregular rhythm notifications say the feature isn’t intended for people under 22 or for anyone previously diagnosed with AFib. That second limit surprises people. If you already have AFib, the alert wasn’t designed for you; AFib History, which tracks how often you’re in AFib, was built for that group instead.
Sleep apnea notifications carry their own boundary: adults 18 and older who haven’t been diagnosed with sleep apnea. The hypertension feature has a different catch. It doesn’t measure your blood pressure at all. It looks for patterns over roughly 30-day windows and suggests you check with a cuff and talk to a doctor.
Why Your Country Gets It Later
FDA clearance only covers the United States. Every other market has its own regulator and its own paperwork. Europe requires CE marking under the Medical Device Regulation, the UK has the MHRA, Australia has the TGA, and China has the NMPA. Each one wants its own submission, sometimes its own local data, and its own labeling in the local language.
That’s why Apple’s support pages repeat the same line about the ECG app being available only in certain countries and regions. The feature works the same everywhere, but it isn’t legally allowed everywhere. Changing your region settings to get it early doesn’t change that, and it may leave you using a feature no regulator reviewed for your market.
What the Label Doesn’t Promise
Clearance is not a diagnosis. An irregular rhythm alert means the algorithm saw a pattern worth checking. Your doctor still has to confirm what’s going on, usually with a clinical ECG or longer monitoring.
It also doesn’t work in reverse. No notification doesn’t mean nothing is wrong. Apple says plainly that these features won’t catch every case, and none of them is meant to replace regular checkups or to help you decide on your own whether to change a medication.
Reading the Label the Right Way
The next time you see “FDA cleared” on an Apple Watch feature, read it as “reviewed for a specific job, for specific people, in one country.” Three habits help:
- Open the instructions for use for any health feature you rely on and check the age and diagnosis limits.
- Treat an alert as a reason to call your doctor, never as the final answer.
- If a feature isn’t available where you live, wait for your own regulator rather than working around it.
